2021
DOI: 10.1039/d0bm01881c
|View full text |Cite
|
Sign up to set email alerts
|

A polymeric nanoformulation improves the bioavailability and efficacy of sorafenib for hepatocellular carcinoma therapy

Abstract: A nanoparticle-based formulation of sorafenib (NP-sfb) significantly inhibited hepatocellular carcinoma by suppressing angiogenesis and promoting cytotoxic T lymphocyte infiltration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 35 publications
0
6
0
Order By: Relevance
“…Some drugs, such as sorafenib, have a tumoricidal effect; however, their clinical application is limited due to poor water solubility, fast metabolism, and low oral bioavailability. The nano-delivery system can improve the water solubility and bioavailability of drugs [ 94 , 95 , 142 ]. Chen et al used clinically safe poly(ethylene glycol)-b-poly(lactic acid) as a nanocarrier to deliver sorafenib (NP-sfb), and the inhibition of NP-sfb on tumor growth was significantly stronger than that of free SFB at the same dose, indicating that nanoparticles successfully increased the bioavailability of SFB [ 94 ].…”
Section: Progress In Treatment Of Hcc and Application Of Nanotechnologymentioning
confidence: 99%
“…Some drugs, such as sorafenib, have a tumoricidal effect; however, their clinical application is limited due to poor water solubility, fast metabolism, and low oral bioavailability. The nano-delivery system can improve the water solubility and bioavailability of drugs [ 94 , 95 , 142 ]. Chen et al used clinically safe poly(ethylene glycol)-b-poly(lactic acid) as a nanocarrier to deliver sorafenib (NP-sfb), and the inhibition of NP-sfb on tumor growth was significantly stronger than that of free SFB at the same dose, indicating that nanoparticles successfully increased the bioavailability of SFB [ 94 ].…”
Section: Progress In Treatment Of Hcc and Application Of Nanotechnologymentioning
confidence: 99%
“…The sorafenib-loaded nanoparticles based on PEG-b-PLA showed satisfactory inhibitory efficacy for HCC cell lines. Conversely, the nanoparticles displayed low cytotoxicity to the normal hepatocyte with the same treatment conditions [ 113 ]. PLGA is one of the synthetic biodegradable polymers obtained from lactic and glycolic acid.…”
Section: Delivery Carriers Of Mtkismentioning
confidence: 99%
“…Hence, a variety of microwave sensitizing nanomaterials have been developed [ 11 14 ], such as organic materials (gelatin, sodium alginate microcapsules) [ 15 ], inorganic materials [ 16 18 ] (zirconium dioxide hollow nanospheres [ 19 ], carbon nanotubes [ 20 22 ]), organic–inorganic hybrid materials (metal organic framework [ 23 25 ]). Amongst, synthesis methods and the targeting ability of the organic materials need to be improved [ 26 , 27 ]. The inorganic nanomaterials are unable to be metabolized and difficult to be eliminated from the body, which limits their clinical applications [ 28 30 ].…”
Section: Introductionmentioning
confidence: 99%